Page 25 - 《中国药房》2023年20期

Pharmacol Ther，2013，38（7）：729-740. AGREE Ⅱ instrument[J]. Ann Med Surg，2022，79：
[35] SONDAK V K，WONG S L，GERSHENWALD J E，et al. 103887.
Evidence-based clinical practice guidelines on the use of [45] GUAN J L，HU Y L，AN P，et al. Comparison of high-
sentinel lymph node biopsy in melanoma[J/OL]. Am Soc dose dual therapy with bismuth-containing quadruple
Clin Oncol Educ Book，2013[2023-05-11]. https：//pubmed. therapy in Helicobacter pylori-infected treatment-naive
ncbi.nlm.nih.gov/23714536/.DOI：10.14694/EdBook_AM. patients：an open-label，multicenter，randomized con‐
2013.33.e320. trolled trial[J]. Pharmacotherapy，2022，42（3）：224-232.
[36] MAJEWSKI M，SAROSIEK I，COOPER C J，et al. Ga- [46] HAN Y Y，LONG H，LIN Y，et al. Optimized dual therapy
stric pH and therapeutic responses to exsomeprazole in for treatment-naive patients of Helicobacter pylori infec‐
patients with functional dyspepsia： potential clinical tion：a large-scale prospective，multicenter，open-label，
implications[J]. Am J Med Sci，2016，352（6）：582-592. randomized controlled study[J]. Helicobacter，2022，27
[37] KAMIYA T，SHIKANO M，KUBOTA E，et al. A multi‐ （5）：e12922.
center randomized trial comparing rabeprazole and ito‐ [47] SHAO Q Q，YU X C，YU M，et al. Rabeprazole plus
pride in patients with functional dyspepsia in Japan：the amoxicillin dual therapy is equally effective to bismuth-
NAGOYA study[J]. J Clin Biochem Nutr，2017，60（2）： containing quadruple therapy for Helicobacter pylori
130-135. eradication in central China：a single-center，prospective，
[38] YANG J C，LIN C J，WANG H L，et al. High-dose dual open-label，randomized-controlled trial[J]. Helicobacter，
therapy is superior to standard first-line or rescue therapy 2022，27（2）：e12876.
for Helicobacter pylori infection[J]. Clin Gastroenterol [48] ANZIĆ S A，TURKALJ M，ŽUPAN A，et al. Eight weeks
Hepatol，2015，13（5）：895-905. of omeprazole 20 mg significantly reduces both laryngo‐
[39] ZENG Y，YE Y T，LIANG D S，et al. Meta-analysis of the pharyngeal reflux and comorbid chronic rhinosinusitis
efficacy of lansoprazole and omeprazole for the treatment signs and symptoms： randomised，double-blind，placebo-
of H. pylori-associated duodenal ulcer[J]. Int J Physiol controlled trial[J]. Clin Otolaryngol，2018，43（2）：
Pathophysiol Pharmacol，2015，7（3）：158-164. 496-501.
[40] YANG J，ZHANG Y，FAN L，et al. Eradication efficacy of [49] CHENG A C. Melioidosis：advances in diagnosis and
modified dual therapy compared with bismuth-containing treatment[J]. Curr Opin Infect Dis，2010，23（6）：554-559.
quadruple therapy as a first-line treatment of Helicobacter [50] SANFORD A P. 热病：桑福德抗微生物治疗指南[M]. 50
pylori[J]. Am J Gastroenterol，2019，114（3）：437-445. 版.北京：中国协和医科大学出版社，2021：73.
[41] HWONG-RUEY LEOW A，CHANG J V，GOH K L. SANFORD A P. Fever：Sanford antibiotic treatment guide‐
Searching for an optimal therapy for H. pylori eradication： lines[M]. 50 edition. Beijing：Peking Union Medical Col‐
high-dose proton-pump inhibitor dual therapy with amoxi‐ lege Press，2021：73.
cillin vs. standard triple therapy for 14 days[J]. Helico‐ [51] 中国微生物学会医学微生物学与免疫学专业委员会，重
bacter，2020，25（5）：e12723. 庆市微生物学会临床微生物专业委员会，毛旭虎，等. 类
[42] XU H M，WANG W C，MA X N，et al. Comparative effi‐ 鼻疽诊断与治疗专家共识[J]. 中华传染病杂志，2022，40
cacy and safety of high-dose dual therapy，bismuth-based （10）：577-583.
quadruple therapy and non-bismuth quadruple therapies Medical Microbiology and Immunology Committee of
for Helicobacter pylori infection：a network meta-analysis Chinese Society for Microbiology，Clinical Microbiology
[J]. Eur J Gastroenterol Hepatol，2021，33（6）：775-786. Committee of Chongqing Society for Microbiology，MAO
[43] 中华医学会消化病学分会幽门螺杆菌学组 . 2022 中国 X H，et al. Expert consensus on diagnosis and treatment of
幽门螺杆菌感染治疗指南[J]. 中华消化杂志，2022，42 melioidosis[J]. Chin J Infect Dis，2022，40（10）：577-583.
（11）：745-756. [52] PAUL M，SHANI V，MUCHTAR E，et al. Systematic re‐
Helicobacter pylori Study Group，Society of Gastroentero- view and meta-analysis of the efficacy of appropriate em‐
logy，Chinese Medical Association. 2022 Chinese national piric antibiotic therapy for sepsis[J]. Antimicrob Agents
clinical practice guideline on Helicobacter pylori eradica‐ Chemother，2010，54（11）：4851-4863.
tion treatment[J]. Chin J Dig，2022，42（11）：745-756. [53] 中国老年医学学会，国家老年疾病临床医学研究中心，
[44] BABIKER MOHAMED M A， ABDELWAHAB 解放军老年医学专业委员会. 感染诱发的老年多器官功
ABDELKARIM W A，SALIH AABDEEN M A，et al. 能障碍综合征诊断与治疗中国指南2019[J]. 中华老年多
Evidence-based clinical practice guidelines for the ma- 器官疾病杂志，2019，18（11）：801-838.
nagement of perioperative hypothermia：systematic re‐ Chinese Geriatrics Society，National Clinical Research
view，critical appraisal，and quality assessment with the Center for Geriatric Diseases，Chinese PLA Geriatric

中国药房 2023年第34卷第20期 China Pharmacy 2023 Vol. 34 No. 20 · 2451 ·